Radial Versus Femoral Arterial Access for Cerebral Angiography in Adolescents

Radial Versus Femoral Arterial Access for Cerebral Angiography in Adolescents: A Randomized-controlled Study

This study will compare radial vs femoral access for angiography in adolescents. Neuroangiography and neurointerventions are predominantly performed via femoral access, which has several limitations and complications - pain and discomfort, arterial occlusion, retroperitoneal hemorrhage, activity limitations, and increased admissions. Transradial angiography has shown promise to circumvent these problems, but this has not been studied in children, whose unique anatomical and physiological aspects require that this be evaluated rigorously.

Study Overview

• Status: Terminated
• Conditions: Patient Satisfaction; Procedural Related Injuries and Complications Nec
• Intervention / Treatment: Procedure: transradial access for neuroangiography; Procedure: transfemoral access for neuroangiography

Detailed Description

Specific Aims:

Angiography in interventional radiology is still most commonly performed through femoral arterial access, wherein patients are committed to invasive procedures through access at their groin, which entails anxiety, embarrassment, pain and discomfort, the inability to resume normal activities for a week, serious complications like retroperitoneal hemorrhage, and increased hospital admissions. Angiography through access at the wrist (transradial angiography) has been shown with some recent data to circumvent these complications and, in general, provide a more satisfactory and safe patient experience. Although transradial angiography has been rapidly accepted by some operators, especially in Cardiology, the absence of evidence for technical details and safety has resulted in much debate in the literature and in recent conferences. Specifically, there is no literature reported in children. The benefits of a method which would allow mobility immediately after the procedure in children are self-evident - this would potentially result in less rebleeds, require little or no sedation, allow sitting up and feeding, and allow parents to interact with their child and feel more comfortable. On the flip side, the feasibility and potential complications in children are unknown, and thus this technique cannot be integrated into clinical practice without interrogating this. This should be ideally performed in a high volume pediatric center with expertise in not only pediatric neuroangiography, but also for minimally invasive arterial access with interventional radiology, to minimize complications. Given the size consideration of arteries in children, we believe a good start point for this study would be with adolescent children.

The Investigator's objective is to provide the highest level of evidence (RCT data) for feasibility, safety and technique of transradial angiography in adolescents, by comparing it against the current gold standard, trans-femoral angiography. This will provide data for subsequent practice guidelines.

This study will be performed in a tertiary pediatric institution, with collaboration between interventional radiologists, neuroradiologists, pediatricians, neurosurgeons, technologists, statisticians, research co-ordinators and imaging physicists. A large number of clinical cases, established pipelines for clinical workflow and research collaborations and imaging laboratories with personnel and students would enable us to successfully complete this project in a timely manner.

Neuroangiography and neurointerventions are predominantly performed via femoral access, which has several limitations and complications - pain and discomfort, arterial occlusion, retroperitoneal hemorrhage, activity limitations, and increased admissions. Transradial angiography has shown promise to circumvent these problems, but this has not been studied in children, whose unique anatomical and physiological aspects require that this be evaluated rigorously.

Primary aim:

To evaluate procedural comfort and acceptance of transradial vs. transfemoral neuroangiography in a cohort of randomized adolescent children. This will be performed using patient self-reported pain and satisfaction scores.

Secondary aim:

1. To evaluate procedural safety for transradial vs. transfemoral neuroangiography in a cohort of adolescent children. This will be performed by comparing fluoroscopy time and dose, procedural and long-term complication rates, study completeness and admission times.

Methods: Children (8-18 years) scheduled for supra-aortic angiography will be approached to participate. Inclusion cut-offs: radial artery ultrasound diameter >20mm and positive Allen test. For 95% power (primary aim), the Investigator will require a sample size of 56. Neuroangiography will be performed as clinically indicated, with collection of demographics, procedural details (screening time, radiation dose, completeness and complications) and post-procedural details (visual analog pain scale, satisfaction score, complications). A Data & Safety Monitoring board will audit the trial.

Outcome Measures: Self-reported scores will be compared between groups for procedural acceptance; complications will be compared for procedural safety.

Significance: 1) This study will provide the highest level evidence regarding role and safety of transradial neuroangiography in children. 2) Subsequent development of practice guideline recommendations for a standardized protocol for transradial angiography in children.

• Study Type: Interventional
• Enrollment (Actual): 12
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Canada
  • Ontario
    • Toronto, Ontario, Canada, M5G 1X8
      • Hospital for Sick Children

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 8 years to 18 years (ADULT, CHILD)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

1. Age 8-18 years
2. Planned cerebral or supra-aortic angiography for clinical reason
3. Positive modified Allen's test using a pulse oximeter on the index finger.
4. Radial artery axial maximal diameter of > 2.0 mm measured on a cross-sectional B-mode ultrasound of the distal radial artery, 2-3 cm proximal to the radial styloid, at the anticipated needle puncture site -

Exclusion Criteria:

1. Age <8 years
2. Radial artery internal maximal of diameter 2.0 mm or less (measured on cross-sectional ultrasound 2-3 cm proximal to the radial styloid at the planned puncture site) - these patients would be converted to femoral access without radial artery puncture but would be assessed in the radial artery group as part of an intention-to-treat analysis.
3. Conversion to intervention (as opposed to diagnostic cerebral angiogram) during the procedure, as this will likely require a larger (femoral) access sheath; again such patients will still be assessed as part of the intention-to-treat analysis.

4. Failed modified Allen's test with pulse oximetry

   -

Study Plan

How is the study designed?

Design Details

• Primary Purpose: OTHER
• Allocation: RANDOMIZED
• Interventional Model: PARALLEL
• Masking: NONE

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
ACTIVE_COMPARATOR: transfemoral access; control	Procedure: transradial access for neuroangiography; The choice of right vs left radial artery approach would be determined by the vessels that require the highest quality of imaging (e.g. if the left vertebral artery is key to diagnosis, a left radial approach would be chosen, otherwise a right radial approach would be likely most appropriate) - this decision is at the discretion of the interventionist.; Procedure: transfemoral access for neuroangiography; By convention, femoral access will be obtained on the right side, unless there is overlying disease or vessel abnormality detected by ultrasound/Doppler, as is usual clinical practice.
ACTIVE_COMPARATOR: transradial access; case	Procedure: transradial access for neuroangiography; The choice of right vs left radial artery approach would be determined by the vessels that require the highest quality of imaging (e.g. if the left vertebral artery is key to diagnosis, a left radial approach would be chosen, otherwise a right radial approach would be likely most appropriate) - this decision is at the discretion of the interventionist.; Procedure: transfemoral access for neuroangiography; By convention, femoral access will be obtained on the right side, unless there is overlying disease or vessel abnormality detected by ultrasound/Doppler, as is usual clinical practice.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Procedural access-related complications	access-related complications	intraprocedural
Procedural access-related complications	access-related complications	30 days
Procedural access-related complications	access-related	365 days
other Procedural complications	other procedural complications	intra procedural
other Procedural complications	other procedural complications	30 days
other Procedural complications	other procedural complications	365 days
Procedural complications-completion rate	study completion rate	intraprocedural
Procedural complications - long term	long term complications	30 days
pain score	visual analog scale VAS with 0=no pain, and 10 being worst pain	3 hours post-procedure
patient/parent satisfaction score	modified Likert scale-0=unsatisfied, and 5=completely satisfied	3 days post-procedure

Collaborators and Investigators

• Sponsor: The Hospital for Sick Children

Study record dates

Study Major Dates

• Study Start (ACTUAL): September 22, 2020
• Primary Completion (ACTUAL): June 1, 2021
• Study Completion (ACTUAL): June 1, 2021

Study Registration Dates

• First Submitted: October 1, 2020
• First Submitted That Met QC Criteria: October 21, 2020
• First Posted (ACTUAL): October 27, 2020

Study Record Updates

• Last Update Posted (ACTUAL): October 28, 2021
• Last Update Submitted That Met QC Criteria: October 20, 2021
• Last Verified: October 1, 2021

More Information

Terms related to this study

• Other Study ID Numbers: 1000065604

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No